Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring compression resistance	PODN PRELP CHADL	2.66e-06	23	24	3	GO:0030021
GeneOntologyMolecularFunction	histone H3K27me2/H3K27me3 demethylase activity	KDM6A UTY	1.38e-05	5	24	2	GO:0071558
GeneOntologyMolecularFunction	N6-methyladenosine-containing RNA reader activity	YTHDF2 YTHDF3	1.44e-04	15	24	2	GO:1990247
GeneOntologyMolecularFunction	protein-RNA adaptor activity	YTHDF2 YTHDF3	3.76e-04	24	24	2	GO:0140517
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM6A UTY	5.13e-04	28	24	2	GO:0141052
GeneOntologyMolecularFunction	histone demethylase activity	KDM6A UTY	6.30e-04	31	24	2	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	KDM6A UTY	6.72e-04	32	24	2	GO:0140457
GeneOntologyMolecularFunction	demethylase activity	KDM6A UTY	1.27e-03	44	24	2	GO:0032451
GeneOntologyMolecularFunction	extracellular matrix structural constituent	PODN PRELP CHADL	1.44e-03	188	24	3	GO:0005201
GeneOntologyMolecularFunction	miRNA binding	PUM2 RBM10	1.51e-03	48	24	2	GO:0035198
GeneOntologyMolecularFunction	regulatory RNA binding	PUM2 RBM10	2.51e-03	62	24	2	GO:0061980
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM6A UTY	2.75e-03	65	24	2	GO:0016706
GeneOntologyMolecularFunction	double-stranded RNA binding	RC3H2 TLR3	3.93e-03	78	24	2	GO:0003725
GeneOntologyMolecularFunction	collagen binding	PODN CHADL	4.23e-03	81	24	2	GO:0005518
GeneOntologyMolecularFunction	dioxygenase activity	KDM6A UTY	6.13e-03	98	24	2	GO:0051213
GeneOntologyMolecularFunction	mRNA binding	PUM2 RC3H2 YTHDF2 YTHDF3	8.83e-03	694	24	4	GO:0003729
GeneOntologyBiologicalProcess	stress granule assembly	PUM2 YTHDF2 YTHDF3	9.64e-06	36	24	3	GO:0034063
GeneOntologyBiologicalProcess	nucleic acid catabolic process	PUM2 DFFB RC3H2 RBM10 YTHDF2 YTHDF3	1.20e-05	464	24	6	GO:0141188
GeneOntologyBiologicalProcess	regulation of mRNA stability	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	1.87e-05	292	24	5	GO:0043488
GeneOntologyBiologicalProcess	regulation of RNA stability	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	2.42e-05	308	24	5	GO:0043487
GeneOntologyBiologicalProcess	regulation of mRNA catabolic process	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	2.46e-05	309	24	5	GO:0061013
GeneOntologyBiologicalProcess	actin filament-based movement	UTY LIMCH1 SYNE2 WAS	2.76e-05	153	24	4	GO:0030048
GeneOntologyBiologicalProcess	mRNA catabolic process	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	6.03e-05	373	24	5	GO:0006402
GeneOntologyBiologicalProcess	mRNA destabilization	PUM2 RC3H2 YTHDF2 YTHDF3	8.78e-05	206	24	4	GO:0061157
GeneOntologyBiologicalProcess	RNA destabilization	PUM2 RC3H2 YTHDF2 YTHDF3	9.63e-05	211	24	4	GO:0050779
GeneOntologyBiologicalProcess	positive regulation of mRNA catabolic process	PUM2 RC3H2 YTHDF2 YTHDF3	9.63e-05	211	24	4	GO:0061014
GeneOntologyBiologicalProcess	nucleobase-containing compound catabolic process	PUM2 DFFB RC3H2 RBM10 YTHDF2 YTHDF3	1.16e-04	696	24	6	GO:0034655
GeneOntologyBiologicalProcess	RNA catabolic process	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	1.20e-04	432	24	5	GO:0006401
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	1.36e-04	443	24	5	GO:1903311
GeneOntologyBiologicalProcess	positive regulation of mRNA metabolic process	PUM2 RC3H2 YTHDF2 YTHDF3	2.12e-04	259	24	4	GO:1903313
GeneOntologyBiologicalProcess	negative regulation of type I interferon-mediated signaling pathway	YTHDF2 YTHDF3	3.53e-04	24	24	2	GO:0060339
GeneOntologyBiologicalProcess	regulation of catabolic process	PUM2 DFFB RC3H2 RBM10 YTHDF2 YTHDF3 TAB3	4.14e-04	1252	24	7	GO:0009894
GeneOntologyBiologicalProcess	positive regulation of translational initiation	YTHDF2 YTHDF3	5.17e-04	29	24	2	GO:0045948
GeneOntologyBiologicalProcess	non-canonical NF-kappaB signal transduction	RC3H2 TAB3 TLR3	6.82e-04	150	24	3	GO:0038061
GeneOntologyCellularComponent	cytoplasmic stress granule	PUM2 RC3H2 YTHDF2 YTHDF3	4.14e-06	96	24	4	GO:0010494
GeneOntologyCellularComponent	MLL3/4 complex	KDM6A UTY	8.28e-05	12	24	2	GO:0044666
GeneOntologyCellularComponent	P-body	RC3H2 YTHDF2 YTHDF3	2.12e-04	102	24	3	GO:0000932
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	PUM2 RC3H2 YTHDF2 YTHDF3	2.33e-04	269	24	4	GO:0036464
GeneOntologyCellularComponent	ribonucleoprotein granule	PUM2 RC3H2 YTHDF2 YTHDF3	2.98e-04	287	24	4	GO:0035770
GeneOntologyCellularComponent	extracellular matrix	PODN PRELP CHADL FLRT1 TLR3	7.76e-04	656	24	5	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	PODN PRELP CHADL FLRT1 TLR3	7.87e-04	658	24	5	GO:0030312
Domain	LRR_8	PODN PRELP LRRC8B CHADL FLRT1 TLR3	6.33e-08	171	24	6	PF13855
Domain	Leu-rich_rpt_typical-subtyp	PODN PRELP LRRC8B CHADL FLRT1 TLR3	7.77e-08	177	24	6	IPR003591
Domain	LRR_TYP	PODN PRELP LRRC8B CHADL FLRT1 TLR3	7.77e-08	177	24	6	SM00369
Domain	LRRNT	PODN PRELP CHADL FLRT1 TLR3	1.41e-07	98	24	5	IPR000372
Domain	LRRNT	PODN PRELP CHADL FLRT1 TLR3	1.41e-07	98	24	5	SM00013
Domain	LRR	PODN PRELP LRRC8B CHADL FLRT1 TLR3	1.65e-07	201	24	6	PS51450
Domain	LRR_1	PODN PRELP LRRC8B CHADL FLRT1 TLR3	2.74e-07	219	24	6	PF00560
Domain	Leu-rich_rpt	PODN PRELP LRRC8B CHADL FLRT1 TLR3	9.54e-07	271	24	6	IPR001611
Domain	-	PODN PRELP LRRC8B CHADL FLRT1 TLR3	2.55e-06	321	24	6	3.80.10.10
Domain	L_dom-like	PODN PRELP LRRC8B CHADL FLRT1 TLR3	2.89e-06	328	24	6	IPR032675
Domain	YTH	YTHDF2 YTHDF3	1.58e-05	5	24	2	PS50882
Domain	YTH_domain	YTHDF2 YTHDF3	1.58e-05	5	24	2	IPR007275
Domain	YTH	YTHDF2 YTHDF3	1.58e-05	5	24	2	PF04146
Domain	LRRNT	PODN PRELP FLRT1	4.19e-05	53	24	3	PF01462
Domain	LRR_5	PODN LRRC8B	7.08e-05	10	24	2	PF13306
Domain	LRR_5	PODN LRRC8B	7.08e-05	10	24	2	IPR026906
Domain	Cys-rich_flank_reg_C	CHADL FLRT1 TLR3	2.04e-04	90	24	3	IPR000483
Domain	LRRCT	CHADL FLRT1 TLR3	2.04e-04	90	24	3	SM00082
Domain	zf-RanBP	RBM10 TAB3	3.60e-04	22	24	2	PF00641
Domain	ZnF_RBZ	RBM10 TAB3	3.94e-04	23	24	2	SM00547
Domain	ZF_RANBP2_2	RBM10 TAB3	3.94e-04	23	24	2	PS50199
Domain	JmjC	KDM6A UTY	4.29e-04	24	24	2	PF02373
Domain	ZF_RANBP2_1	RBM10 TAB3	4.29e-04	24	24	2	PS01358
Domain	Znf_RanBP2	RBM10 TAB3	4.66e-04	25	24	2	IPR001876
Domain	JMJC	KDM6A UTY	7.67e-04	32	24	2	PS51184
Domain	JmjC_dom	KDM6A UTY	7.67e-04	32	24	2	IPR003347
Domain	JmjC	KDM6A UTY	8.15e-04	33	24	2	SM00558
Domain	TPR_8	KDM6A UTY	2.10e-03	53	24	2	PF13181
Domain	CH	LIMCH1 SYNE2	3.13e-03	65	24	2	SM00033
Domain	CH	LIMCH1 SYNE2	3.62e-03	70	24	2	PF00307
Domain	-	LIMCH1 SYNE2	3.73e-03	71	24	2	1.10.418.10
Domain	CH	LIMCH1 SYNE2	3.93e-03	73	24	2	PS50021
Domain	CH-domain	LIMCH1 SYNE2	4.15e-03	75	24	2	IPR001715
Domain	TPR_1	KDM6A UTY	5.92e-03	90	24	2	PF00515
Domain	TPR_1	KDM6A UTY	5.92e-03	90	24	2	IPR001440
Domain	TPR	KDM6A UTY	1.18e-02	129	24	2	SM00028
Domain	TPR_repeat	KDM6A UTY	1.25e-02	133	24	2	IPR019734
Domain	TPR-contain_dom	KDM6A UTY	1.58e-02	150	24	2	IPR013026
Domain	TPR	KDM6A UTY	1.88e-02	165	24	2	PS50005
Domain	TPR_REGION	KDM6A UTY	1.88e-02	165	24	2	PS50293
Pathway	REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX	TAB3 TLR3	5.01e-05	11	14	2	M27885
Pathway	REACTOME_HDMS_DEMETHYLATE_HISTONES	KDM6A UTY	3.66e-04	29	14	2	MM14934
Pubmed	Positive and negative selection on mammalian Y chromosomes.	KDM6A UTY	4.56e-07	2	24	2	15758204
Pubmed	Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.	KDM6A UTY	4.56e-07	2	24	2	31097364
Pubmed	An H-YDb epitope is encoded by a novel mouse Y chromosome gene.	KDM6A UTY	4.56e-07	2	24	2	8944031
Pubmed	Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons.	KDM6A UTY	4.56e-07	2	24	2	18434530
Pubmed	YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.	YTHDF2 YTHDF3	4.56e-07	2	24	2	32905781
Pubmed	Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.	KDM6A UTY	4.56e-07	2	24	2	27533081
Pubmed	Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq.	YTHDF2 YTHDF3	1.37e-06	3	24	2	22575960
Pubmed	YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA.	YTHDF2 YTHDF3	1.37e-06	3	24	2	28106072
Pubmed	YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation.	YTHDF2 YTHDF3	1.37e-06	3	24	2	35508130
Pubmed	Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.	YTHDF2 YTHDF3	1.37e-06	3	24	2	34497675
Pubmed	m6A modification controls the innate immune response to infection by targeting type I interferons.	YTHDF2 YTHDF3	1.37e-06	3	24	2	30559377
Pubmed	YTH: a new domain in nuclear proteins.	YTHDF2 YTHDF3	1.37e-06	3	24	2	12368078
Pubmed	The UTX gene escapes X inactivation in mice and humans.	KDM6A UTY	1.37e-06	3	24	2	9499428
Pubmed	A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA.	YTHDF2 YTHDF3	1.37e-06	3	24	2	32492408
Pubmed	m6A-binding YTHDF proteins promote stress granule formation.	YTHDF2 YTHDF3	1.37e-06	3	24	2	32451507
Pubmed	m6A enhances the phase separation potential of mRNA.	YTHDF2 YTHDF3	1.37e-06	3	24	2	31292544
Pubmed	N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression.	YTHDF2 YTHDF3	1.37e-06	3	24	2	27371828
Pubmed	Groucho/transducin-like enhancer of split (TLE) family members interact with the yeast transcriptional co-repressor SSN6 and mammalian SSN6-related proteins: implications for evolutionary conservation of transcription repression mechanisms.	KDM6A UTY	2.74e-06	4	24	2	9854018
Pubmed	X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.	KDM6A UTY	2.74e-06	4	24	2	32732223
Pubmed	Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility.	KDM6A UTY	2.74e-06	4	24	2	10767340
Pubmed	N6-methyladenosine-dependent regulation of messenger RNA stability.	YTHDF2 YTHDF3	2.74e-06	4	24	2	24284625
Pubmed	Context-dependent functional compensation between Ythdf m6A reader proteins.	YTHDF2 YTHDF3	4.56e-06	5	24	2	32943573
Pubmed	Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation.	DFFB TLR3	6.83e-06	6	24	2	16301743
Pubmed	UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling.	KDM6A UTY	9.56e-06	7	24	2	29551674
Pubmed	Phenotypic annotation of the mouse X chromosome.	KDM6A RBM10 TAB3	1.01e-05	61	24	3	20548051
Pubmed	UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death.	KDM6A UTY	1.27e-05	8	24	2	36412518
Pubmed	Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.	KDM6A YTHDF2 WAS	1.47e-05	69	24	3	32238831
Pubmed	UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development.	KDM6A UTY	1.64e-05	9	24	2	23028370
Pubmed	UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity.	KDM6A UTY	1.64e-05	9	24	2	22949634
Pubmed	pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.	TAB3 TLR3	2.50e-05	11	24	2	10066798
Pubmed	Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy.	PODN PRELP	2.50e-05	11	24	2	12796502
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	PUM2 RBM10 YTHDF2 YTHDF3	2.80e-05	258	24	4	37794589
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	KDM6A UTY	3.54e-05	13	24	2	14660691
Pubmed	Global gene expression analysis in fetal mouse ovaries with and without meiosis and comparison of selected genes with meiosis in the testis.	SYT9 TAB3	3.54e-05	13	24	2	17431699
Pubmed	UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program.	KDM6A UTY	3.54e-05	13	24	2	22192413
Pubmed	Human transcription factor protein interaction networks.	PUM2 KDM6A RBM10 YTHDF2 YTHDF3 TAB3 SYNE2	3.64e-05	1429	24	7	35140242
Pubmed	KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis.	KDM6A UTY	5.44e-05	16	24	2	35212626
Pubmed	Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .	TAB3 TLR3	6.17e-05	17	24	2	12609980
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	KDM6A UTY	6.94e-05	18	24	2	12023983
Pubmed	m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs.	YTHDF2 YTHDF3	7.75e-05	19	24	2	36039295
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	RBM10 YTHDF2 YTHDF3 LIMCH1	8.17e-05	340	24	4	24332808
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	KDM6A UTY	8.61e-05	20	24	2	19047629
Pubmed	A quantitative atlas of mitotic phosphorylation.	RBM10 YTHDF3	8.61e-05	20	24	2	18669648
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	PUM2 RBM10 YTHDF2 TLR3 WAS	1.11e-04	714	24	5	28302793
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	1.17e-04	723	24	5	34133714
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CPED1 PUM2 RC3H2 YTHDF2 YTHDF3	1.18e-04	724	24	5	36232890
Pubmed	The m6A reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells.	YTHDF2 YTHDF3	1.25e-04	24	24	2	35179492
Pubmed	The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine.	YTHDF2 YTHDF3	1.36e-04	25	24	2	35874829
Pubmed	Functional coherence of the human Y chromosome.	KDM6A UTY	1.36e-04	25	24	2	9381176
Pubmed	SSRI treatment modifies the effects of maternal inflammation on in utero physiology and offspring neurobiology.	UTY TLR3	1.36e-04	25	24	2	36343752
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	CPED1 RBM10 YTHDF3 LIMCH1 SYNE2	1.39e-04	750	24	5	11230166
Pubmed	Identification and characterization of a novel human PP1 phosphatase complex.	KDM6A RBM10	2.10e-04	31	24	2	20516061
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	PODN FLRT1 TLR3 PCDH12	2.60e-04	460	24	4	20562862
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	PUM2 RBM10 YTHDF2 YTHDF3	2.65e-04	462	24	4	31138677
Pubmed	Mettl14-mediated m6A modification ensures the cell-cycle progression of late-born retinal progenitor cells.	YTHDF2 YTHDF3	2.68e-04	35	24	2	37269288
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	APBB2 RBM10 SYNE2	2.85e-04	187	24	3	26460568
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	YTHDF2 YTHDF3 SYNE2	3.32e-04	197	24	3	20811636
Pubmed	Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing.	CPED1 RBM10 YTHDF3 LIMCH1	4.23e-04	523	24	4	11256614
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	CPED1 PODN LRRC8B FLRT1 PCDH12	4.90e-04	985	24	5	12975309
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	RC3H2 RBM10 YTHDF2 LIMCH1	5.01e-04	547	24	4	37267103
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	KDM6A UTY	5.26e-04	49	24	2	34368113
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	PUM2 RBM10 YTHDF2 YTHDF3 SYNE2	5.41e-04	1007	24	5	34597346
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	KDM6A UTY	5.48e-04	50	24	2	37974198
Pubmed	Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.	TAB3 SYNE2	6.63e-04	55	24	2	18570454
Pubmed	Identification of differential protein interactors of lamin A and progerin.	RBM10 SYNE2	6.63e-04	55	24	2	21327095
Interaction	CNOT6L interactions	RC3H2 YTHDF2 YTHDF3 TLR3	4.21e-06	93	24	4	int:CNOT6L
Interaction	RNF214 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	6.57e-06	104	24	4	int:RNF214
Interaction	R3HDM2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.54e-05	129	24	4	int:R3HDM2
Interaction	CELF1 interactions	PUM2 RC3H2 RBM10 YTHDF2 YTHDF3	1.96e-05	288	24	5	int:CELF1
Interaction	DAZL interactions	PUM2 RC3H2 YTHDF2 YTHDF3	2.44e-05	145	24	4	int:DAZL
Interaction	YTHDF1 interactions	PUM2 PRELP RC3H2 YTHDF2 YTHDF3	2.46e-05	302	24	5	int:YTHDF1
Interaction	CPEB4 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	3.25e-05	156	24	4	int:CPEB4
Interaction	CNOT2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	5.45e-05	178	24	4	int:CNOT2
Interaction	PAIP2 interactions	PUM2 RC3H2 YTHDF2	5.62e-05	63	24	3	int:PAIP2
Interaction	ZFP36 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	5.81e-05	181	24	4	int:ZFP36
Interaction	ALG13 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	6.06e-05	183	24	4	int:ALG13
Interaction	PAN3 interactions	RC3H2 YTHDF2 YTHDF3	6.18e-05	65	24	3	int:PAN3
Interaction	SMAP2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	6.87e-05	189	24	4	int:SMAP2
Interaction	FAM120C interactions	PUM2 RC3H2 YTHDF2 YTHDF3	7.16e-05	191	24	4	int:FAM120C
Interaction	MKRN2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3 SYNE2	7.81e-05	385	24	5	int:MKRN2
Interaction	CNOT8 interactions	RC3H2 YTHDF2 YTHDF3	9.10e-05	74	24	3	int:CNOT8
Interaction	RBM47 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	9.24e-05	204	24	4	int:RBM47
Interaction	CNOT3 interactions	RC3H2 YTHDF2 YTHDF3 TAB3	9.78e-05	207	24	4	int:CNOT3
Interaction	RBMS1 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	9.78e-05	207	24	4	int:RBMS1
Interaction	UNK interactions	PUM2 RC3H2 YTHDF2 YTHDF3 LIMCH1	1.03e-04	408	24	5	int:UNK
Interaction	SECISBP2 interactions	RC3H2 YTHDF2 YTHDF3	1.06e-04	78	24	3	int:SECISBP2
Interaction	ZC3H7A interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.13e-04	215	24	4	int:ZC3H7A
Interaction	MEX3B interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.28e-04	222	24	4	int:MEX3B
Interaction	ANKRD17 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.37e-04	226	24	4	int:ANKRD17
Interaction	SMG6 interactions	RC3H2 YTHDF2 YTHDF3	1.37e-04	85	24	3	int:SMG6
Interaction	CNOT9 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.49e-04	231	24	4	int:CNOT9
Interaction	SYNCRIP interactions	APBB2 SYT9 RC3H2 RBM10 YTHDF2 YTHDF3	1.59e-04	721	24	6	int:SYNCRIP
Interaction	OTUD4 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.62e-04	236	24	4	int:OTUD4
Interaction	LARP4B interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.73e-04	240	24	4	int:LARP4B
Interaction	YTHDF3 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.90e-04	246	24	4	int:YTHDF3
Interaction	HELZ interactions	PUM2 RC3H2 YTHDF2 YTHDF3	2.25e-04	257	24	4	int:HELZ
Interaction	LSM14A interactions	PUM2 RC3H2 YTHDF2 YTHDF3	2.35e-04	260	24	4	int:LSM14A
Interaction	PRRC2B interactions	PUM2 RC3H2 YTHDF2 YTHDF3	2.52e-04	265	24	4	int:PRRC2B
Interaction	AKAP1 interactions	APBB2 PUM2 YTHDF2 YTHDF3 TAB3	2.72e-04	503	24	5	int:AKAP1
Interaction	CNOT11 interactions	RC3H2 YTHDF2 YTHDF3	3.11e-04	112	24	3	int:CNOT11
Interaction	TNRC6B interactions	PUM2 RC3H2 YTHDF2 YTHDF3	3.20e-04	282	24	4	int:TNRC6B
Interaction	ZCCHC2 interactions	YTHDF2 YTHDF3	3.39e-04	23	24	2	int:ZCCHC2
Interaction	PUM1 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	3.42e-04	287	24	4	int:PUM1
Interaction	USP10 interactions	RC3H2 RBM10 YTHDF2 YTHDF3	3.56e-04	290	24	4	int:USP10
Interaction	FUBP3 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	3.89e-04	297	24	4	int:FUBP3
Interaction	UBAP2L interactions	PUM2 RC3H2 YTHDF2 YTHDF3	3.94e-04	298	24	4	int:UBAP2L
Interaction	EIF4ENIF1 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	4.04e-04	300	24	4	int:EIF4ENIF1
Interaction	YTHDF2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	4.69e-04	312	24	4	int:YTHDF2
Interaction	SMG7 interactions	RC3H2 RBM10 YTHDF2 YTHDF3	5.10e-04	319	24	4	int:SMG7
Interaction	CNOT7 interactions	RC3H2 YTHDF2 YTHDF3	5.97e-04	140	24	3	int:CNOT7
Interaction	CNOT10 interactions	RC3H2 YTHDF2 YTHDF3	6.09e-04	141	24	3	int:CNOT10
Interaction	PUM2 interactions	PUM2 YTHDF2 YTHDF3	6.48e-04	144	24	3	int:PUM2
Interaction	CPEB1 interactions	PUM2 YTHDF2 YTHDF3	6.74e-04	146	24	3	int:CPEB1
Interaction	FAM120A interactions	PUM2 RC3H2 YTHDF2 YTHDF3	7.14e-04	349	24	4	int:FAM120A
Interaction	IGF2BP2 interactions	PUM2 RC3H2 YTHDF2 YTHDF3	7.77e-04	357	24	4	int:IGF2BP2
Interaction	PCDH17 interactions	FLRT1 PCDH12	8.35e-04	36	24	2	int:PCDH17
Interaction	DCP1A interactions	RC3H2 YTHDF2 YTHDF3	9.78e-04	166	24	3	int:DCP1A
Interaction	CEP85 interactions	RC3H2 YTHDF2 YTHDF3	1.03e-03	169	24	3	int:CEP85
Interaction	PRRC2A interactions	PUM2 RC3H2 YTHDF2 YTHDF3	1.07e-03	389	24	4	int:PRRC2A
Interaction	RBM39 interactions	PUM2 RC3H2 RBM10 YTHDF2 TLR3 WAS	1.13e-03	1042	24	6	int:RBM39
Interaction	PATL1 interactions	RC3H2 YTHDF2 YTHDF3	1.18e-03	177	24	3	int:PATL1
Interaction	EIF4G2 interactions	RC3H2 YTHDF2 YTHDF3	1.22e-03	179	24	3	int:EIF4G2
Cytoband	4p13	APBB2 LIMCH1	5.47e-05	21	24	2	4p13
Cytoband	Ensembl 112 genes in cytogenetic band chr4p13	APBB2 LIMCH1	1.21e-04	31	24	2	chr4p13
Cytoband	Ensembl 112 genes in cytogenetic band chrXp11	KDM6A RBM10 WAS	9.78e-04	377	24	3	chrXp11
Cytoband	Ensembl 112 genes in cytogenetic band chr1p32	DIO1 PODN	2.98e-03	155	24	2	chr1p32
GeneFamily	Small leucine rich repeat proteoglycans	PODN PRELP	4.82e-05	12	16	2	573
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RBM10 TAB3	1.53e-04	21	16	2	89
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM6A UTY	2.00e-04	24	16	2	485
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	KDM6A UTY	4.54e-03	115	16	2	769
Coexpression	NABA_PROTEOGLYCANS	PODN PRELP CHADL	4.33e-06	35	24	3	M5882
Coexpression	NABA_PROTEOGLYCANS	PODN PRELP CHADL	4.72e-06	36	24	3	MM17061
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 PODN PRELP LIMCH1	3.26e-06	193	24	4	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 PODN PRELP LIMCH1	3.26e-06	193	24	4	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	PND28-Mesenchymal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 PODN PRELP LIMCH1	3.47e-06	196	24	4	119265efd2219f328d8152dbee52af8327aec89c
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	APBB2 KDM6A UTY LIMCH1	3.68e-06	199	24	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRELP LIMCH1 FLRT1	7.55e-05	154	24	3	44d4d99b08216c0901e3bc32743fa0a8b85b5149
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KDM6A UTY SYNE2	7.84e-05	156	24	3	1545169694f686d28648a68b552c2ae606599d66
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CPED1 PODN PRELP	8.30e-05	159	24	3	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1\|TCGA-Kidney / Sample_Type by Project: Shred V9	SYT9 TLR3 PCDH12	8.61e-05	161	24	3	6cacae4a759ace763597ee394cff498dc5d96f74
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	KDM6A UTY SYNE2	8.77e-05	162	24	3	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODN SYNE2 FLRT1	9.60e-05	167	24	3	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODN SYNE2 FLRT1	9.60e-05	167	24	3	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODN SYNE2 FLRT1	1.07e-04	173	24	3	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODN SYNE2 FLRT1	1.07e-04	173	24	3	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DIO1 PRELP LIMCH1	1.08e-04	174	24	3	3c47d069bd836599a8d40eae485c23d4d3487517
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRELP TLR3 PCDH12	1.10e-04	175	24	3	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRELP TLR3 PCDH12	1.10e-04	175	24	3	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.10e-04	175	24	3	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN KDM6A	1.12e-04	176	24	3	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.14e-04	177	24	3	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	UTY PRELP SYNE2	1.14e-04	177	24	3	605f71515c877bb4de4121675ec8c1318a2500a7
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APBB2 UTY PCDH12	1.14e-04	177	24	3	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.14e-04	177	24	3	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 PRELP PCDH12	1.20e-04	180	24	3	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 PRELP PCDH12	1.20e-04	180	24	3	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	KDM6A UTY SYNE2	1.22e-04	181	24	3	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.22e-04	181	24	3	c26d3cbbc592299786d79d1b15fc6bead2aafb9a
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMCH1 SYNE2 PCDH12	1.24e-04	182	24	3	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	APBB2 PRELP CHADL	1.24e-04	182	24	3	00a148b1e499bf16325491536d187d4dd6b70c06
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.28e-04	184	24	3	fea4fe648e9749177d0783443dc26a7df5807883
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.28e-04	184	24	3	96a8a0a190bc293655fe7d80cbed8119c0da25f2
ToppCell	facs-Skin-Skin_Anagen-18m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.28e-04	184	24	3	780eb72da43527f0c72effac3423ec7384f05f20
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.28e-04	184	24	3	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.30e-04	185	24	3	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	E12.5-Endothelial-capillary_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LIMCH1 TLR3 PCDH12	1.30e-04	185	24	3	e005d3c01a908157f780bbc1d53dd2ed814a39d2
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.30e-04	185	24	3	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	E12.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LIMCH1 TLR3 PCDH12	1.30e-04	185	24	3	0bccc424d0466f7f82baa00127c733640a2d50fb
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.30e-04	185	24	3	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 LIMCH1 SYNE2	1.32e-04	186	24	3	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT9 LIMCH1 SYNE2	1.34e-04	187	24	3	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODN PRELP LIMCH1	1.38e-04	189	24	3	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODN PRELP LIMCH1	1.38e-04	189	24	3	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PODN PRELP LIMCH1	1.38e-04	189	24	3	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODN PRELP LIMCH1	1.41e-04	190	24	3	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 LIMCH1 PCDH12	1.43e-04	191	24	3	827be47d3574c6c5b021c6f1c1670834344f10cb
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 LIMCH1 PCDH12	1.43e-04	191	24	3	a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PODN PRELP LIMCH1	1.43e-04	191	24	3	ce80f65bd24b1c4d2152bf45248449e7a1a97e56
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPED1 PODN PRELP	1.43e-04	191	24	3	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	droplet-Lung-1m-Mesenchymal\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PODN PRELP LIMCH1	1.45e-04	192	24	3	01433bd4794b8bcc51fe4249124a0f4289b9d6e2
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 PODN PRELP	1.45e-04	192	24	3	cdc652dbfabe41b324fd85c1ed933d29fb73a49f
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 PODN PRELP	1.45e-04	192	24	3	29bee88b45e23f16543ffc7cc361bc5da5d16a2b
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	KDM6A UTY SYNE2	1.45e-04	192	24	3	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 PRELP PCDH12	1.47e-04	193	24	3	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	COVID-19_Severe-CD8+_T_activated\|World / disease group, cell group and cell class	UTY SYNE2 TLR3	1.47e-04	193	24	3	ddc1db516568e03be8e82b2ca770c67756418185
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 PRELP PCDH12	1.47e-04	193	24	3	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.47e-04	193	24	3	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 PRELP PCDH12	1.47e-04	193	24	3	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.49e-04	194	24	3	f4c9fc53ae31d58096906d9305b0b4082512a7e9
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYT9 LIMCH1 CHADL	1.49e-04	194	24	3	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PODN PRELP LIMCH1	1.49e-04	194	24	3	7826fe5eb254ac032de0d978f39585a40e0b3ee4
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.49e-04	194	24	3	bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCell	facs-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.49e-04	194	24	3	fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.49e-04	194	24	3	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.49e-04	194	24	3	6afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.52e-04	195	24	3	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 PODN PRELP	1.52e-04	195	24	3	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Bronchial_Biopsy-Mesenchymal-Fibroblasts\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	CPED1 PODN PRELP	1.52e-04	195	24	3	5870b2956d50d6550a3174a220a6cc70c5538d70
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.52e-04	195	24	3	095b8e0be385b6390420589124a95fa4ba3682ab
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.52e-04	195	24	3	223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.54e-04	196	24	3	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PODN PRELP	1.54e-04	196	24	3	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	Bronchial_Biopsy-Mesenchymal\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	CPED1 PODN PRELP	1.54e-04	196	24	3	d37d821229dce716a05c2a5865415e10f79032de
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CPED1 PODN LIMCH1	1.56e-04	197	24	3	4e0c3ea4f4a04a41532806edf3bccf7845c86fa5
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODN PRELP LIMCH1	1.56e-04	197	24	3	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPED1 PRELP LIMCH1	1.56e-04	197	24	3	eb07545bef5ad506fbbe3a1f99131f26c1447a31
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.56e-04	197	24	3	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPED1 PODN LIMCH1	1.56e-04	197	24	3	69fde2d27881f8408216e231c71cfdbd96f28d45
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CPED1 PODN PRELP	1.59e-04	198	24	3	c7075dce915ab8387309fcb12c5f6a17d4100cda
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	APBB2 KDM6A LIMCH1	1.59e-04	198	24	3	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	CPED1 PODN PRELP	1.59e-04	198	24	3	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	PODN PRELP LIMCH1	1.59e-04	198	24	3	2d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPED1 PODN LIMCH1	1.59e-04	198	24	3	d83707b69fb64721ac3cff90ba58cdd999d6b386
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PODN PRELP LIMCH1	1.59e-04	198	24	3	08d393853e195a7eacace454153e425a273e2d23
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPED1 PODN LIMCH1	1.61e-04	199	24	3	ec74ff85d6b61013b1f785b2fca343759feb7843
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LIMCH1 SYNE2 PCDH12	1.61e-04	199	24	3	14e09eaa2335d4503de50250eb4258dd5b85b304
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.61e-04	199	24	3	e9009eee7f77b9c9917f8e0e723001d9e76eb553
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	medial-mesenchymal-Airway_Smooth_Muscle\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPED1 PODN PRELP	1.63e-04	200	24	3	c1d9748aaae489d26e24602a5dcbe7f5fa9a5548
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	251fd2923f108cd2086961d897244b392c32ad54
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial\|5w / Sample Type, Dataset, Time_group, and Cell type.	CPED1 PRELP WAS	1.63e-04	200	24	3	69707f9576d326a06faac49701ef5cd632e760f6
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	CPED1 PRELP WAS	1.63e-04	200	24	3	f94381d0a3b5b81cdbb13b75fc0e4910cbd70382
ToppCell	medial-mesenchymal-Airway_Smooth_Muscle-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPED1 PODN PRELP	1.63e-04	200	24	3	6a5047018b12be3bc4b55a64d42e52e96c624003
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MOK PODN PRELP	1.63e-04	200	24	3	8a4c210a3130f7baedf15ecbc0f4903b97da0352
ToppCell	medial-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CPED1 PODN PRELP	1.63e-04	200	24	3	16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c
ToppCell	Kidney-Fibroblasts\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	PODN PRELP LRRC8B	1.63e-04	200	24	3	2c265ad8314a21bce50ac21b16da2fea125366ea
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 PODN PRELP	1.63e-04	200	24	3	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	CPED1 PRELP LRRC8B	1.63e-04	200	24	3	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	distal-3-mesenchymal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PODN PRELP LIMCH1	1.63e-04	200	24	3	7a79a2de78325d4f1c4535969106a0a44249028c
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A	APBB2 KDM6A UTY RC3H2 LIMCH1	1.51e-06	192	24	5	7155_DN
Drug	Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A	MOK APBB2 UTY DFFB PCDH12	1.59e-06	194	24	5	6774_DN
Drug	0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A	KDM6A UTY LIMCH1 WAS	3.78e-05	183	24	4	7389_DN
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A	KDM6A DFFB LIMCH1 WAS	4.66e-05	193	24	4	4616_DN
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A	MOK UTY LIMCH1 PCDH12	4.85e-05	195	24	4	7323_UP
Drug	Picrotoxinin [17617-45-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	APBB2 KDM6A RC3H2 LIMCH1	4.85e-05	195	24	4	4260_DN
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A	MOK APBB2 CPED1 WAS	4.95e-05	196	24	4	3435_UP
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A	KDM6A UTY DFFB LIMCH1	4.95e-05	196	24	4	4984_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A	APBB2 UTY LRRC8B WAS	4.95e-05	196	24	4	4439_DN
Drug	N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	MOK APBB2 UTY WAS	5.04e-05	197	24	4	5332_UP
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A	APBB2 CPED1 UTY LIMCH1	5.14e-05	198	24	4	4798_DN
Drug	Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MOK UTY WAS PCDH12	5.14e-05	198	24	4	7332_UP
Drug	Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A	UTY PRELP LRRC8B PCDH12	5.14e-05	198	24	4	2570_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	APBB2 CPED1 UTY PRELP	5.14e-05	198	24	4	4301_UP
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A	MOK APBB2 LIMCH1 WAS	5.14e-05	198	24	4	7322_UP
Drug	Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	UTY DFFB WAS PCDH12	5.14e-05	198	24	4	7357_UP
Drug	estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	APBB2 UTY LIMCH1 WAS	5.25e-05	199	24	4	5960_DN
Drug	Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A	APBB2 KDM6A LRRC8B LIMCH1	5.25e-05	199	24	4	5994_UP
Drug	Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; PC3; HT_HG-U133A	APBB2 UTY RC3H2 WAS	5.25e-05	199	24	4	7271_DN
Drug	Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; MCF7; HT_HG-U133A	MOK APBB2 KDM6A RBM10	5.35e-05	200	24	4	7436_UP
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A	APBB2 UTY LIMCH1 WAS	5.35e-05	200	24	4	665_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA	LIMCH1 WAS PCDH12	7.50e-04	171	24	3	991_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	APBB2 PUM2 KDM6A	7.89e-04	174	24	3	7530_DN
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A	PUM2 KDM6A DFFB	8.70e-04	180	24	3	5779_DN
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HG-U133A	APBB2 CPED1 KDM6A	8.99e-04	182	24	3	1905_UP
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	APBB2 PUM2 LRRC8B	9.42e-04	185	24	3	1114_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	CPED1 DFFB LRRC8B	9.87e-04	188	24	3	3770_DN
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; PC3; HT_HG-U133A	KDM6A LRRC8B WAS	1.00e-03	189	24	3	1807_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	APBB2 CPED1 UTY	1.00e-03	189	24	3	5084_DN
Drug	5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA	MOK KDM6A LIMCH1	1.03e-03	191	24	3	844_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A	CPED1 KDM6A PCDH12	1.06e-03	193	24	3	6734_DN
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A	UTY WAS PCDH12	1.08e-03	194	24	3	3816_UP
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	KDM6A LIMCH1 WAS	1.08e-03	194	24	3	898_UP
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A	APBB2 UTY LIMCH1	1.08e-03	194	24	3	3404_UP
Drug	ST021200; Up 200; 10uM; PC3; HT_HG-U133A	APBB2 KDM6A RC3H2	1.08e-03	194	24	3	7493_UP
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	APBB2 UTY LIMCH1	1.08e-03	194	24	3	3828_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	UTY WAS PCDH12	1.08e-03	194	24	3	6779_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	APBB2 UTY WAS	1.08e-03	194	24	3	3422_UP
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	APBB2 CPED1 WAS	1.08e-03	194	24	3	7000_UP
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; HL60; HT_HG-U133A	KDM6A DFFB RC3H2	1.08e-03	194	24	3	2405_DN
Drug	Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A	APBB2 UTY LIMCH1	1.08e-03	194	24	3	5355_UP
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A	KDM6A RC3H2 LIMCH1	1.08e-03	194	24	3	4221_DN
Drug	5666823; Down 200; 100uM; MCF7; HG-U133A	MOK APBB2 KDM6A	1.10e-03	195	24	3	609_DN
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A	APBB2 UTY LIMCH1	1.10e-03	195	24	3	3757_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; HL60; HT_HG-U133A	CPED1 LRRC8B PCDH12	1.10e-03	195	24	3	2364_UP
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	KDM6A UTY RBM10	1.10e-03	195	24	3	7152_DN
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	CPED1 LIMCH1 PCDH12	1.10e-03	195	24	3	4746_UP
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A	APBB2 CPED1 KDM6A	1.10e-03	195	24	3	3663_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A	APBB2 CPED1 LIMCH1	1.10e-03	195	24	3	7394_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	KDM6A LRRC8B WAS	1.10e-03	195	24	3	2884_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	APBB2 LIMCH1 WAS	1.10e-03	195	24	3	3871_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	APBB2 LIMCH1 WAS	1.10e-03	195	24	3	3710_DN
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	APBB2 CPED1 RC3H2	1.10e-03	195	24	3	2126_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	APBB2 KDM6A PRELP	1.11e-03	196	24	3	1495_UP
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MOK DFFB WAS	1.11e-03	196	24	3	7330_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	APBB2 UTY LIMCH1	1.11e-03	196	24	3	7377_DN
Drug	Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; MCF7; HT_HG-U133A	APBB2 PRELP LRRC8B	1.11e-03	196	24	3	2245_UP
Drug	Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A	UTY LIMCH1 FLRT1	1.11e-03	196	24	3	2862_UP
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; HL60; HT_HG-U133A	LRRC8B LIMCH1 FLRT1	1.11e-03	196	24	3	2707_UP
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; PC3; HT_HG-U133A	APBB2 RC3H2 LIMCH1	1.11e-03	196	24	3	4218_DN
Drug	radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A	RC3H2 RBM10 FLRT1	1.11e-03	196	24	3	493_UP
Drug	Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MOK APBB2 PCDH12	1.11e-03	196	24	3	5322_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	APBB2 KDM6A UTY	1.11e-03	196	24	3	2072_UP
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	APBB2 DFFB RBM10	1.11e-03	196	24	3	5833_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	UTY PRELP PCDH12	1.11e-03	196	24	3	5807_UP
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; PC3; HT_HG-U133A	DFFB RC3H2 LRRC8B	1.11e-03	196	24	3	6703_DN
Drug	Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	APBB2 KDM6A WAS	1.11e-03	196	24	3	5505_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	APBB2 KDM6A LIMCH1	1.11e-03	196	24	3	4359_DN
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	APBB2 UTY PCDH12	1.11e-03	196	24	3	6571_DN
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	KDM6A UTY DFFB	1.11e-03	196	24	3	7277_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	APBB2 KDM6A WAS	1.11e-03	196	24	3	7265_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HT_HG-U133A	APBB2 KDM6A RC3H2	1.11e-03	196	24	3	4257_DN
Drug	Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	APBB2 DFFB LIMCH1	1.11e-03	196	24	3	7321_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CPED1 LIMCH1 FLRT1	1.13e-03	197	24	3	3605_UP
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	UTY RBM10 WAS	1.13e-03	197	24	3	282_UP
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A	MOK UTY DFFB	1.13e-03	197	24	3	7354_UP
Drug	Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	APBB2 LIMCH1 WAS	1.13e-03	197	24	3	6009_UP
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A	KDM6A LIMCH1 WAS	1.13e-03	197	24	3	2892_DN
Drug	Atracurium besylate [64228-81-5]; Up 200; 3.2uM; PC3; HT_HG-U133A	APBB2 KDM6A RC3H2	1.13e-03	197	24	3	1824_UP
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	APBB2 PRELP FLRT1	1.13e-03	197	24	3	3133_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A	KDM6A DFFB LIMCH1	1.13e-03	197	24	3	4986_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; HL60; HG-U133A	APBB2 RBM10 WAS	1.13e-03	197	24	3	1608_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A	MOK APBB2 KDM6A	1.13e-03	197	24	3	7419_UP
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MOK UTY LIMCH1	1.13e-03	197	24	3	5353_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	KDM6A DFFB LRRC8B	1.13e-03	197	24	3	1180_DN
Disease	Kabuki syndrome (implicated_via_orthology)	KDM6A UTY	1.90e-06	3	24	2	DOID:0060473 (implicated_via_orthology)
Disease	disease of metabolism (implicated_via_orthology)	YTHDF2 YTHDF3	1.32e-04	21	24	2	DOID:0014667 (implicated_via_orthology)
Disease	colorectal cancer (is_implicated_in)	KDM6A RBM10	4.34e-03	121	24	2	DOID:9256 (is_implicated_in)
Disease	renal cell carcinoma (is_marker_for)	MOK KDM6A	4.84e-03	128	24	2	DOID:4450 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PNTLNLRSSHNELLN	APBB2	36	Q92870
NALEHLLQRSRPLEN	CPED1	836	A4D0V7
QAPQRQRLLADLLHN	DFFB	111	O76075
NLNRLRPHLELLANI	RC3H2	346	Q9HBD1
ENANDTIILRNLNPH	RBM10	296	P98175
NNRFPNLQLRDLIGH	PUM2	716	Q8TB72
NHPRQRNASRENLNL	PCDH12	851	Q9NPG4
LSRLHRLETLNLQNN	PODN	116	Q7Z5L7
HLEQLRANRNNLNPA	KDM6A	476	O15550
NNLREIQALRRLNPH	MOK	46	Q9UQ07
SLNNLHELDLRENNL	LRRC8B	606	Q6P9F7
NLQDRLQAAHLLLAR	DIO1	176	P49895
NLPRSLRELHLQDNN	FLRT1	96	Q9NZU1
NLASNHLRELPQEAL	CHADL	116	Q6NUI6
PHSRARQEQLQLINN	LIMCH1	341	Q9UPQ0
RHNSIRRQLNLSNPD	SYT9	166	Q86SS6
QHLEQLRANRDNLNP	UTY	426	O14607
SLQQLLRLQDDHRNL	SYNE2	1941	Q8WXH0
PDDNRMNRNRLLHIN	TAB3	61	Q8N5C8
NLLLLDLQHNRLSDG	PRELP	196	P51888
VPNNQLRHIRLENND	YTHDF3	511	Q7Z739
LNLTHNQLRRLPAAN	TLR3	56	O15455
NIPSTLLQDHENQRL	WAS	21	P42768
PNSQLRHIRLENNEN	YTHDF2	506	Q9Y5A9